| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P356 | DOI | 10.1002/14651858.CD004863.PUB5 |
| P8608 | Fatcat ID | release_mxix6kassnfevmxro7cvogdvu4 |
| P932 | PMC publication ID | 6486170 |
| P698 | PubMed publication ID | 29145693 |
| P2093 | author name string | Arne Ohlsson | |
| Sanjay M Aher | |||
| P2860 | cites work | Erythropoietin therapy for premature infants: cost without benefit? | Q74112088 |
| Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g | Q74390917 | ||
| Effect of recombinant human erythropoietin on transfusion needs in preterm infants | Q74452004 | ||
| Efficacy of erythropoietin in premature infants | Q77894500 | ||
| Comparison between two and five doses a week of recombinant human erythropoietin for anemia of prematurity: a randomized trial | Q78070318 | ||
| Effect of recombinant human erythropoietin in preterm infants | Q78237359 | ||
| Effects of erythropoietin on erythrocyte deformability in non-transfused preterm infants | Q80148849 | ||
| Single-dose darbepoetin administration to anemic preterm neonates | Q81189218 | ||
| Changes in thrombopoiesis and platelet reactivity in extremely low birth weight infants undergoing erythropoietin therapy for treatment of anaemia of prematurity | Q81225782 | ||
| Recombinant human erythropoietin therapy in low-birthweight preterm infants: a prospective controlled study | Q81366765 | ||
| The effect of early recombinant erythropoietin and enteral iron supplementation on blood transfusion in preterm infants | Q81471297 | ||
| Erythropoietin and retinopathy of prematurity: a meta-analysis | Q87923641 | ||
| Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants | Q24195000 | ||
| Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants | Q24200513 | ||
| Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants | Q24200642 | ||
| Low versus high haemoglobin concentration threshold for blood transfusion for preventing morbidity and mortality in very low birth weight infants | Q24235360 | ||
| Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants | Q24245091 | ||
| Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants | Q24245263 | ||
| Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants | Q24245418 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Darbepoetin Administration in Term and Preterm Neonates | Q28085116 | ||
| Development and characterization of novel erythropoiesis stimulating protein (NESP) | Q28362976 | ||
| Improving the quality of reporting of randomized controlled trials. The CONSORT statement | Q29619101 | ||
| Erythropoietin in the neonate | Q33636837 | ||
| Using a count of neonatal morbidities to predict poor outcome in extremely low birth weight infants: added role of neonatal infection | Q33693432 | ||
| The use of erythropoietin in neonates | Q34032616 | ||
| Association between early administration of high-dose erythropoietin in preterm infants and brain MRI abnormality at term-equivalent age. | Q34041820 | ||
| The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential | Q34199255 | ||
| Effect of recombinant erythropoietin on "late" transfusions in the neonatal intensive care unit: a meta-analysis | Q34565026 | ||
| Erythropoietin protects intestinal epithelial barrier function and lowers the incidence of experimental neonatal necrotizing enterocolitis | Q34752092 | ||
| Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage | Q35023300 | ||
| Recombinant erythropoietin and blood transfusion in selected preterm infants | Q35556474 | ||
| Cognitive outcomes of preterm infants randomized to darbepoetin, erythropoietin, or placebo | Q35935811 | ||
| Comparison of oral recombinant erythropoietin and subcutaneous recombinant erythropoietin in prevention of anemia of prematurity. | Q36022650 | ||
| Preschool Assessment of Preterm Infants Treated With Darbepoetin and Erythropoietin | Q36630778 | ||
| A randomized, masked, placebo-controlled study of darbepoetin alfa in preterm infants | Q36952268 | ||
| Recombinant human erythropoietin improves neurological outcomes in very preterm infants | Q37375616 | ||
| Erythropoietin in neonatal brain protection: the past, the present and the future. | Q37812501 | ||
| Do transfusions cause necrotizing enterocolitis? The complementary role of randomized trials and observational studies | Q38028051 | ||
| Neuroprotective role of erythropoietin in neonates | Q38041616 | ||
| Neuroprotective effects of erythropoiesis-stimulating agents in term and preterm neonates | Q38188856 | ||
| Neuroprotection with erythropoietin in preterm and/or low birth weight infants | Q38197787 | ||
| Erythropoietin: emerging role of erythropoietin in neonatal neuroprotection | Q38255341 | ||
| A meta-analysis of the protective effect of recombinant human erythropoietin (rhEPO) for neurodevelopment in preterm infants | Q38258586 | ||
| Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years: A Randomized Clinical Trial | Q38392485 | ||
| Prophylactic Early Erythropoietin for Neuroprotection in Preterm Infants: A Meta-analysis | Q38677277 | ||
| Red blood cell transfusion of preterm neonates with a Grade 1 intraventricular hemorrhage is associated with extension to a Grade 3 or 4 hemorrhage | Q39113597 | ||
| Anemia of prematurity. Current concepts in the issue of when to transfuse. | Q39728647 | ||
| Current issues in neonatal transfusions | Q39740201 | ||
| Erythropoiesis, erythropoietin, and iron. | Q40246449 | ||
| Changing patterns of red blood cell transfusion in very low birth weight infants. | Q40922497 | ||
| Recombinant human erythropoietin in neonatal anemia | Q40922889 | ||
| Safety of Early High-Dose Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants | Q41343253 | ||
| Tract-based spatial statistics to assess the neuroprotective effect of early erythropoietin on white matter development in preterm infants. | Q41656923 | ||
| Neurodevelopmental outcome of prematurely born children treated with recombinant human erythropoietin in infancy | Q41721043 | ||
| Transfusion practices in infants receiving assisted ventilation | Q41729755 | ||
| Effects of early parenteral iron combined erythropoietin in preterm infants: A randomized controlled trial | Q41918130 | ||
| A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety | Q42664024 | ||
| Iron supplementation enhances response to high doses of recombinant human erythropoietin in preterm infants | Q42967326 | ||
| An approach to using recombinant erythropoietin for neuroprotection in very preterm infants | Q43716045 | ||
| How to administrate erythropoietin, intravenous or subcutaneous? | Q44587055 | ||
| Effects of early human recombinant erythropoietin therapy on the transfusion in healthy preterm infants | Q46213274 | ||
| Why study erythropoietin in preterm infants? | Q46453494 | ||
| Enteral granulocyte-colony stimulating factor and erythropoietin early in life improves feeding tolerance in preterm infants: a randomized controlled trial | Q46570740 | ||
| A comparison of high versus low dose recombinant human erythropoietin versus blood transfusion in the management of anaemia of prematurity in a developing country | Q46677199 | ||
| Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms | Q47172249 | ||
| Erythropoietin treatment in extremely low birth weight infants: blood in versus blood out. | Q47182794 | ||
| Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial | Q47201469 | ||
| Effect of short-term recombinant human erythropoietin therapy in the prevention of anemia of prematurity in very low birth weight neonates. | Q47244611 | ||
| Effect of beginning recombinant erythropoietin treatment within the first week of life, among very-low-birth-weight neonates, on "early" and "late" erythrocyte transfusions: a meta-analysis | Q47262085 | ||
| High-versus low-dose erythropoietin in extremely low birth weight infants. The European Multicenter rhEPO Study Group | Q47288790 | ||
| Effects of a combined therapy of erythropoietin, iron, folate, and vitamin B12 on the transfusion requirements of extremely low birth weight infants | Q47315155 | ||
| Impact of Erythropoiesis-Stimulating Agents on Behavioral Measures in Children Born Preterm. | Q47344689 | ||
| Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity | Q47349671 | ||
| Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomized, placebo-controlled trial | Q47357954 | ||
| The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group | Q47376367 | ||
| Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron | Q47402202 | ||
| Transfusion-Related Acute Gut Injury: Necrotizing Enterocolitis in Very Low Birth Weight Neonates after Packed Red Blood Cell Transfusion | Q47406234 | ||
| Comparison between one and three doses a week of recombinant erythropoietin in very low birth weight infants | Q47420479 | ||
| Counterbalanced Comparison of the BSID-II and Bayley-III at Eighteen to Twenty-two Months Corrected Age. | Q47715262 | ||
| Randomized trial of early erythropoietin supplementation after preterm birth: Iron metabolism and outcome | Q47912377 | ||
| Pediatrics: neuroprotective effects of erythropoietin in preterm infants | Q48173335 | ||
| Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy | Q48495331 | ||
| Decreased transfusions in preterm infants with anemia treated with erythropoietin | Q50235062 | ||
| A randomized, controlled trial of the effects of adding vitamin B12 and folate to erythropoietin for the treatment of anemia of prematurity. | Q50729717 | ||
| The effect of recombinant human erythropoietin on circulating hematopoietic progenitor cells in anemic premature infants. | Q51107356 | ||
| Early Erythropoietin Administration does not Increase the Risk of Retinopathy in Preterm Infants. | Q51282095 | ||
| Erythropoietin improves neurodevelopmental outcome of extremely preterm infants. | Q51772762 | ||
| Erythropoietin concentrations and neurodevelopmental outcome in preterm infants. | Q51913726 | ||
| [Early use of recombinant human erythropoietin promotes neurobehavioral development in preterm infants]. | Q51947563 | ||
| [Efficacy of early erythropoietin use in critically ill, very-low-birthweight premature newborn infants: controlled clinical trial] | Q64967444 | ||
| Anemia of prematurity | Q67297967 | ||
| Physiological anaemia of infancy and the anaemia of prematurity | Q67340225 | ||
| Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants | Q68196690 | ||
| Prediction of the need for transfusion during anemia of prematurity | Q68505221 | ||
| Efficacy and safety of recombinant human erythropoietin to prevent the anaemias of prematurity. European Randomized Multicenter Trial | Q70168423 | ||
| Pharmacokinetics and effectiveness of recombinant erythropoietin administered to preterm infants by continuous infusion in total parenteral nutrition solution | Q71050007 | ||
| [Evaluation of treatment results for anemia of prematurity treated with various doses of human recombinant erythropoietin] | Q71133731 | ||
| Incidence, severity, and timing of subependymal and intraventricular hemorrhages in preterm infants born in a perinatal unit as detected by serial real-time ultrasound | Q71694475 | ||
| Postnatal changes in erythropoietin levels in untransfused premature infants | Q72712592 | ||
| In which neonates does early recombinant human erythropoietin treatment prevent anemia of prematurity? Results of a randomized, controlled study | Q72714646 | ||
| Use of erythropoietin and its effects on blood lactate and 2, 3-diphosphoglycerate in premature neonates | Q73227689 | ||
| Blood transfusion. Iron load and retinopathy of prematurity | Q73478410 | ||
| Early erythropoietin use for the prevention of anemia in infant premature | Q73560725 | ||
| Meta-analysis of controlled clinical trials studying the efficacy of rHuEPO in reducing blood transfusions in the anemia of prematurity | Q73685494 | ||
| Preventive effect of different dosage of recombinant human erythropoietin on anemia of premature infants | Q73780372 | ||
| The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: a randomized, double-blind, placebo-controlled study | Q73951556 | ||
| P921 | main subject | birth mass | Q4128476 |
| preterm infant | Q45051448 | ||
| P304 | page(s) | CD004863 | |
| P577 | publication date | 2017-11-16 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Early erythropoiesis-stimulating agents in preterm or low birth weight infants. | |
| P478 | volume | 11 |
| Q60045646 | Bronchopulmonary Dysplasia: An Update of Current Pharmacologic Therapies and New Approaches |
| Q102320342 | Can cord blood sampling delay the first packed red blood cell transfusion? |
| Q60949885 | Darbepoetin Alfa in Young Infants With Renal Failure: Single Center Experience, a Case Series and Review of the Literature |
| Q91644629 | Epidemiology of Necrotizing Enterocolitis: New Considerations Regarding the Influence of Red Blood Cell Transfusions and Anemia |
| Q57300205 | Erythropoietin serum levels, versus anaemia as risk factors for severe retinopathy of prematurity |
| Q91676167 | Late erythropoiesis-stimulating agents to prevent red blood cell transfusion in preterm or low birth weight infants |
| Q59800488 | Oxidative Stress as a Primary Risk Factor for Brain Damage in Preterm Newborns |
| Q64070205 | Prevention, Reduction and Repair of Brain Injury of the Preterm Infant |
| Q89667013 | Recent advances in perinatal neuroprotection |
Search more.